No Street GP LP raised its stake in shares of Equifax Inc. (NYSE:EFX - Free Report) by 12.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 118,582 shares of the credit services provider's stock after buying an additional 13,582 shares during the quarter. Equifax comprises 2.0% of No Street GP LP's portfolio, making the stock its 16th largest holding. No Street GP LP owned approximately 0.10% of Equifax worth $30,221,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in EFX. McClarren Financial Advisors Inc. bought a new stake in shares of Equifax during the 4th quarter valued at about $25,000. Colonial Trust Co SC boosted its position in shares of Equifax by 505.0% during the 4th quarter. Colonial Trust Co SC now owns 121 shares of the credit services provider's stock valued at $31,000 after acquiring an additional 101 shares during the last quarter. Spire Wealth Management boosted its position in shares of Equifax by 98.7% during the 4th quarter. Spire Wealth Management now owns 151 shares of the credit services provider's stock valued at $38,000 after acquiring an additional 75 shares during the last quarter. Generali Asset Management SPA SGR bought a new stake in shares of Equifax during the 4th quarter valued at about $39,000. Finally, Atala Financial Inc bought a new stake in shares of Equifax during the 4th quarter valued at about $49,000. Hedge funds and other institutional investors own 96.20% of the company's stock.
Wall Street Analysts Forecast Growth
EFX has been the subject of a number of research analyst reports. Wells Fargo & Company dropped their price target on Equifax from $313.00 to $284.00 and set an "overweight" rating for the company in a research report on Monday, April 14th. Royal Bank of Canada restated an "outperform" rating and issued a $300.00 target price on shares of Equifax in a research report on Wednesday, April 23rd. Oppenheimer dropped their target price on Equifax from $286.00 to $279.00 and set an "outperform" rating for the company in a research report on Friday, February 7th. Gordon Haskett upgraded Equifax to a "strong-buy" rating in a research report on Tuesday, February 18th. Finally, Argus downgraded Equifax from a "buy" rating to a "hold" rating in a research report on Tuesday, February 11th. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $292.00.
Read Our Latest Research Report on Equifax
Insider Activity
In related news, EVP John W. Gamble, Jr. sold 2,000 shares of the company's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $259.10, for a total value of $518,200.00. Following the sale, the executive vice president now directly owns 65,176 shares of the company's stock, valued at $16,887,101.60. This represents a 2.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Mark W. Begor sold 22,160 shares of the company's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $256.61, for a total value of $5,686,477.60. Following the completion of the sale, the chief executive officer now directly owns 142,395 shares in the company, valued at approximately $36,539,980.95. The trade was a 13.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.40% of the company's stock.
Equifax Trading Up 1.3%
EFX stock traded up $3.68 during midday trading on Friday, hitting $278.84. The company had a trading volume of 619,198 shares, compared to its average volume of 965,550. The company has a current ratio of 0.75, a quick ratio of 0.88 and a debt-to-equity ratio of 0.90. Equifax Inc. has a 52 week low of $199.98 and a 52 week high of $309.63. The stock's 50 day moving average price is $243.28 and its 200 day moving average price is $252.72. The stock has a market cap of $34.63 billion, a price-to-earnings ratio of 57.73, a PEG ratio of 2.79 and a beta of 1.68.
Equifax (NYSE:EFX - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The credit services provider reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.45 by $0.08. Equifax had a return on equity of 19.13% and a net margin of 10.63%. The firm had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.41 billion. As a group, equities research analysts expect that Equifax Inc. will post 7.58 earnings per share for the current fiscal year.
Equifax Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, May 23rd. This is a boost from Equifax's previous quarterly dividend of $0.39. This represents a $2.00 annualized dividend and a dividend yield of 0.72%. Equifax's payout ratio is 40.90%.
About Equifax
(
Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
See Also

Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.